Company Filing History:
Years Active: 2022
Title: Rachel Lea Eisenbach: Innovator in T Cell Receptor Technology
Introduction
Rachel Lea Eisenbach is a prominent inventor based in Mazkeret Batia, Israel. She has made significant contributions to the field of immunology, particularly in the development of affinity maturated T cell receptors. Her innovative work has the potential to enhance therapeutic approaches in cancer treatment and other diseases.
Latest Patents
Rachel holds a patent for "Affinity maturated T cell receptors and use thereof." This invention relates to methods and systems for increasing the affinity of a T cell receptor (TCR) to its ligand by subjecting the TCR gene to somatic hypermutation. The patent further explores the use of affinity maturated TCRs to create T cells that are reactive against selected antigens. This advancement could lead to more effective immunotherapies.
Career Highlights
Rachel is associated with Yeda Research and Development Company Ltd., where she continues to push the boundaries of T cell receptor technology. Her work is characterized by a commitment to innovation and a focus on practical applications that can benefit patients.
Collaborations
Some of her notable coworkers include Yosi Gozlan and Esther Tzehoval, who contribute to the collaborative environment that fosters innovation at Yeda Research and Development Company Ltd.
Conclusion
Rachel Lea Eisenbach is a trailblazer in the field of T cell receptor technology, with her patent representing a significant step forward in immunological research. Her contributions are poised to make a lasting impact on the future of medical treatments.